$ANKM
Ankam, Inc.

2022 Q4 Form 10-K Financial Statement

#000178162923000004 Filed on February 24, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $1.760K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $43.81K
YoY Change 106.07%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $13.25K
YoY Change
% of Gross Profit
Operating Expenses $57.05K
YoY Change 168.39%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $13.56K
YoY Change
Pretax Income $55.29K
YoY Change 160.11%
Income Tax
% Of Pretax Income
Net Earnings -$55.29K
YoY Change 160.11%
Net Earnings / Revenue -3141.53%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 4.086M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.280K
YoY Change 159.09%
Cash & Equivalents $2.277K $877.00
Short-Term Investments
Other Short-Term Assets $169.8K $6.735K
YoY Change 5091.13%
Inventory
Prepaid Expenses $3.265K
Receivables $4.800K $4.800K
Other Receivables $0.00
Total Short-Term Assets $176.8K $176.8K $4.142K
YoY Change 4169.17% 4171.26%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $198.7K
YoY Change
Total Long-Term Assets $269.2K $269.2K $6.735K
YoY Change 3897.05% 3894.07%
TOTAL ASSETS
Total Short-Term Assets $176.8K $176.8K $4.142K
Total Long-Term Assets $269.2K $269.2K $6.735K
Total Assets $446.0K $446.0K $10.88K
YoY Change 4000.67% 3999.54%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $123.5K
YoY Change
Accrued Expenses $149.7K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $215.0K
YoY Change 531.11%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $492.2K $492.2K $34.07K
YoY Change 1344.52% 1344.61%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $492.2K $492.2K $34.07K
Total Long-Term Liabilities $0.00
Total Liabilities $492.2K $492.2K $34.07K
YoY Change 1344.52% 1344.61%
SHAREHOLDERS EQUITY
Retained Earnings $81.74K $26.45K
YoY Change 209.08%
Common Stock $4.328K $3.250K
YoY Change 33.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$46.15K -$46.15K -$23.20K
YoY Change
Total Liabilities & Shareholders Equity $446.0K $446.0K $10.88K
YoY Change 4000.67% 3999.54%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$55.29K
YoY Change 160.11%
Depreciation, Depletion And Amortization $13.25K
YoY Change
Cash From Operating Activities $134.9K
YoY Change 450.06%
INVESTING ACTIVITIES
Capital Expenditures $77.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$77.00K
YoY Change 1043.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $32.34K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $213.3K
YoY Change 567.56%
NET CHANGE
Cash From Operating Activities $134.9K
Cash From Investing Activities -$77.00K
Cash From Financing Activities $213.3K
Net Change In Cash $1.400K
YoY Change 102.02%
FREE CASH FLOW
Cash From Operating Activities $134.9K
Capital Expenditures $77.00K
Free Cash Flow $57.89K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001781629
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
usd
CY2021Q4 us-gaap Assets Net
AssetsNet
usd
CY2021Q4 us-gaap Development In Process
DevelopmentInProcess
usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
usd
CY2021Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
usd
CY2021 us-gaap Revenues
Revenues
usd
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
usd
CY2021 none Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
usd
CY2021 none Increase Decrease Project Process
IncreaseDecreaseProjectProcess
usd
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2022 us-gaap Increase Decrease Due From Officers And Stockholders
IncreaseDecreaseDueFromOfficersAndStockholders
usd
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
CY2022 us-gaap Interest Paid
InterestPaid
usd
CY2021 us-gaap Interest Paid
InterestPaid
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
usd
CY2022 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2021 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
333-255392
CY2022 dei Entity Registrant Name
EntityRegistrantName
ANKAM INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
61-1900749
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
5348 Vegas Drive
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Las Vegas
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89108
CY2022 dei City Area Code
CityAreaCode
995
CY2022 dei Local Phone Number
LocalPhoneNumber
599420389
CY2022 dei Contact Personnel Email Address
ContactPersonnelEmailAddress
[email protected]
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
No
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Public Float
EntityPublicFloat
0 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4327996 shares
CY2022 dei Auditor Firm
AuditorFirmId
3289
CY2022 dei Auditor Name
AuditorName
Accell Audit & Compliance, PA
CY2022 dei Auditor Location
AuditorLocation
Tampa, Florida
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
2277 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
877 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4800 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3265 usd
CY2022Q4 us-gaap Assets Net
AssetsNet
169752 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
176829 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
4142 usd
CY2022Q4 us-gaap Development In Process
DevelopmentInProcess
198710 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
70491 usd
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
6735 usd
CY2022Q4 us-gaap Assets
Assets
446030 usd
CY2021Q4 us-gaap Assets
Assets
10877 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
123499 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
4000 usd
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
215017 usd
CY2021Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
34072 usd
CY2022Q4 us-gaap Accrued Rent Current
AccruedRentCurrent
149660 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
492176 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
34072 usd
CY2022Q4 us-gaap Liabilities
Liabilities
492176 usd
CY2021Q4 us-gaap Liabilities
Liabilities
34072 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4327996 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4327996 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3250000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
3250000 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
4328 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3250 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
31262 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
81736 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
26445 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
46146 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23195 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
446030 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10877 usd
CY2022 us-gaap Revenues
Revenues
1760 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26606 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3818 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
17200 usd
CY2021 us-gaap Professional Fees
ProfessionalFees
17439 usd
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
13245 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
57051 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
21257 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
55291 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
21257 usd
CY2022 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
55291 usd
CY2021 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
21257 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4085776 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3250000 shares
CY2020Q4 us-gaap Shares Issued
SharesIssued
3250000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-5188 usd
CY2021 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
3250 shares
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-21257 usd
CY2021Q4 us-gaap Shares Issued
SharesIssued
3250000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-23195 usd
CY2022 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1077996 usd
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
32340 shares
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-55291 usd
CY2022Q4 us-gaap Shares Issued
SharesIssued
4327996 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-46146 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-55291 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-21257 usd
CY2022 us-gaap Amortization And Depreciation Of Decontaminating And Decommissioning Assets
AmortizationAndDepreciationOfDecontaminatingAndDecommissioningAssets
13245 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4800 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-3265 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
3265 usd
CY2022 none Increase Decrease In Right Of Use Assets And Liabilities Net
IncreaseDecreaseInRightOfUseAssetsAndLiabilitiesNet
20093 usd
CY2022 none Increase Decrease Project Process
IncreaseDecreaseProjectProcess
198710 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
123499 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
4000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
134885 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24522 usd
CY2022 none Purchaseof Software
PurchaseofSoftware
-77000 usd
CY2021 none Purchaseof Software
PurchaseofSoftware
-6735 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-77000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6735 usd
CY2021 us-gaap Increase Decrease Due From Officers And Stockholders
IncreaseDecreaseDueFromOfficersAndStockholders
3250 usd
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
32340 usd
CY2022 us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
180945 usd
CY2021 us-gaap Loans And Leases Receivable Related Parties Period Increase Decrease
LoansAndLeasesReceivableRelatedPartiesPeriodIncreaseDecrease
28700 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
213285 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
31950 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1400 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
693 usd
CY2021Q4 us-gaap Cash
Cash
877 usd
CY2020Q4 us-gaap Cash
Cash
184 usd
CY2022Q4 us-gaap Cash
Cash
2277 usd
CY2021Q4 us-gaap Cash
Cash
877 usd
CY2022 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
179592 usd
CY2022 us-gaap Revenue Recognition Allowances
RevenueRecognitionAllowances
<p id="xdx_841_eus-gaap--RevenueRecognitionAllowances_zkIlcymtX0Xg" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_86B_z2rY74HdYAb9">Revenue Recognition</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company recognizes revenue in accordance with Accounting Standards Update (“ASU”) No. 2014-09, <i>"Revenue from Contracts with Customer"</i>. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 1: Identify the contract with a customer</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 2: Identify the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 3: Determine the transaction price</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 4: Allocate the transaction price to the performance obligations in the contract</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0">The Company recognizes revenue when title, ownership, and risk of loss pass to the customer, all of which occurs upon shipment or delivery of the product. There are no additional performance obligations. The transaction price is fixed in the invoice. The company does not apply discounts.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center">15<br/> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>ANKAM INC.</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE AUDITED FINANCIAL STATEMENTS</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2022 AND 2021</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zfQUphxX4nd1" style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="text-decoration: underline"><span id="xdx_864_zPTgLtngUyn7">Use of Estimates</span></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 3pt 0; text-align: center">16<br/> </p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>ANKAM INC.</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOTES TO THE AUDITED FINANCIAL STATEMENTS</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>NOVEMBER 30, 2022 AND 2021</b></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0"> </p>
CY2022Q4 us-gaap Debt Current
DebtCurrent
215017 usd
CY2021Q4 us-gaap Debt Current
DebtCurrent
34072 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
81736 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
26445 usd
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-81736 usd
CY2021 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-26445 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
17165 usd
CY2021Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
5553 usd
CY2022Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
17165 usd
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
5553 usd

Files In Submission

Name View Source Status
0001781629-23-000004-index-headers.html Edgar Link pending
0001781629-23-000004-index.html Edgar Link pending
0001781629-23-000004.txt Edgar Link pending
0001781629-23-000004-xbrl.zip Edgar Link pending
ankam10k_2022.htm Edgar Link pending
exh31.htm Edgar Link pending
exh32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image_001.jpg Edgar Link pending
image_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
none-20221130.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
none-20221130_cal.xml Edgar Link unprocessable
none-20221130_def.xml Edgar Link unprocessable
none-20221130_pre.xml Edgar Link unprocessable
none-20221130_lab.xml Edgar Link unprocessable
ankam10k_2022_htm.xml Edgar Link completed
R20.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable